Fosfomycin's primary brand name in the United States is Monurol [1].
What other forms of Fosfomycin are available?
Outside of the United States, fosfomycin is available in different formulations and brand names, often for intravenous or intramuscular administration. These include Fosfomycin Trometamol (e.g., Monuril, Fosfocina) which is typically used for oral treatment of urinary tract infections [2]. Intravenous formulations exist under brand names like Fosfomycin IV and are used for more serious infections [3].
Why is Fosfomycin being used more frequently?
Fosfomycin is experiencing a resurgence in use due to increasing rates of antibiotic resistance. It is considered a valuable option for treating infections caused by multidrug-resistant bacteria, particularly in urinary tract infections [4]. Its mechanism of action is distinct from many other antibiotics, making it effective against bacteria that have developed resistance to common treatments [5].
How effective is Fosfomycin for UTIs?
Fosfomycin has demonstrated good efficacy in treating uncomplicated urinary tract infections (UTIs). For UTIs, a single oral dose is often sufficient [1]. Its effectiveness extends to treating UTIs caused by common uropathogens, including some resistant strains [4].
Are there concerns about Fosfomycin side effects?
Common side effects associated with oral fosfomycin (Monurol) include diarrhea, nausea, and vaginitis [1]. Intravenous formulations can have more serious side effects, and their use is typically managed in a hospital setting [3].
When does Fosfomycin patent protection expire?
Drug patent information for fosfomycin can vary depending on the specific formulation and the region. For detailed and up-to-date patent expiry information for fosfomycin and its various forms, DrugPatentWatch.com is a resource that tracks these details [6].
Can generic versions of Fosfomycin be produced?
Once patents expire, generic versions of fosfomycin can be manufactured and marketed, potentially leading to lower costs. The availability of generic fosfomycin depends on the patent status of the specific product in question [6].
What is the mechanism of action for Fosfomycin?
Fosfomycin works by inhibiting an early step in bacterial cell wall synthesis. It targets the enzyme MurA (UDP-N-acetylglucosamine enolpyruvyl transferase), which is essential for building the peptidoglycan layer of the bacterial cell wall. This disruption prevents the bacteria from forming a stable cell wall, leading to cell death [5].
How does Fosfomycin compare to other UTI antibiotics?
Fosfomycin offers a distinct advantage in that it is often effective against bacteria that are resistant to other commonly used UTI antibiotics like fluoroquinolones or trimethoprim-sulfamethoxazole [4]. Its single-dose regimen for uncomplicated UTIs also offers convenience compared to multi-day treatments with other antibiotics [1].
What are the regulatory considerations for Fosfomycin use?
In the United States, Monurol is approved by the Food and Drug Administration (FDA) for the treatment of uncomplicated urinary tract infections [1]. Regulatory approvals for different formulations and indications may vary internationally [3].
---
Sources:
1. https://www.drugs.com/monurol.html
2. https://www.drugbank.ca/drugs/DB01034
3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097235/
4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778643/
5. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797297/
6. https://drugpatentwatch.com/